pharmaphorum10y
Diabetes drug Basaglar receives tentative FDA approval
The FDA has granted tentative approval for Basaglar (insulin glargine injection), produced by Eli Lilly and Boehringer Ingelheim's (BI) diabetes alliance, following litigation filed by Sanofi ...
Medscape1y
Patient Satisfaction and Costs Associated With Insulin Administered by Pen Device or Syringe During Hospitalization
NovoFine Autocover 30G disposable safety needles were dispensed for patients enrolled in the pen group. If insulin glargine was prescribed, a vial was dispensed regardless of the treatment group ...